Position in JNJ
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$4,939,716
+$205,403 QoQ
Shares Held
19,450
+0.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#1,623
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FRANKLIN STREET ADVISORS INC /NC holds $55,471,815 across 7 Drug Manufacturers - General names. JNJ ranks #2 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
181,638 | $45,707,386 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
19,450 | $4,939,716 | |
| 3 | AMGN |
Amgen Inc
|
3,408 | $1,234,104 | |
| 4 | LLY |
ELI LILLY & Co
|
1,009 | $1,210,224 | |
| 5 | PFE |
Pfizer Inc
|
46,667 | $1,123,741 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
7,476 | $944,517 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,417 | $312,127 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,939,716 | 19,450 | Shares | Defined | 2026-07-09 | |
| 2026-03-31 | $4,734,313 | 19,368 | Shares | Defined | 2026-04-10 | |
| 2025-12-31 | $4,013,588 | 19,394 | Shares | Defined | 2026-01-21 | |
| 2025-09-30 | $3,568,593 | 19,246 | Shares | Defined | 2025-10-09 | |
| 2025-06-30 | $3,027,657 | 19,821 | Shares | Defined | 2025-07-21 | |
| 2025-03-31 | $3,126,581 | 18,853 | Shares | Defined | 2025-04-15 | |
| 2024-12-31 | $2,779,596 | 19,220 | Shares | Defined | 2025-01-10 | |
| 2024-09-30 | $3,146,394 | 19,415 | Shares | Defined | 2024-10-09 | |
| 2024-06-30 | $3,316,078 | 22,688 | Shares | Defined | 2024-07-18 | |
| 2024-03-31 | $9,807,780 | 62,000 | Shares | Defined | 2024-04-15 | |
| 2023-12-31 | $9,360,356 | 59,719 | Shares | Defined | 2024-01-18 | |
| 2023-09-30 | $10,095,247 | 64,817 | Shares | Defined | 2023-10-10 | |
| 2023-06-30 | $13,271,228 | 80,179 | Shares | Defined | 2023-07-13 | |
| 2023-03-31 | $12,340,635 | 79,617 | Shares | Defined | 2023-04-12 | |
| 2022-12-31 | $21,590,516 | 122,222 | Shares | Defined | 2023-02-07 | |
| 2022-09-30 | $19,491,788 | 119,318 | Shares | Defined | 2022-10-11 | |
| 2022-06-30 | $21,641,131 | 121,915 | Shares | Defined | 2022-07-13 | |
| 2022-03-31 | $14,470,829 | 81,650 | Shares | Defined | 2022-04-18 | |
| 2021-12-31 | $12,722,989 | 74,373 | Shares | Defined | 2022-01-26 | |
| 2021-09-30 | $13,036,603 | 80,722 | Shares | Defined | 2021-10-22 | |
| 2021-06-30 | $13,124,671 | 79,669 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $13,300,352 | 80,927 | Shares | Defined | 2021-05-04 | |
| 2020-12-31 | $12,676,801 | 80,549 | Shares | Defined | 2021-02-01 | |
| 2020-09-30 | $11,859,631 | 79,659 | Shares | Defined | 2020-10-21 | |
| 2020-06-30 | $11,141,271 | 79,224 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $10,423,654 | 79,491 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||